ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BMS, Ono Pharma and Merck resolve PD-1 antibody patent litigation
January 24, 2017Merck to pay BMS and Ono royalties on global sales of Keytruda through 2026, and lump-sum payment of $625 million. -
Bristol-Myers Squibb, Ono settle patent lawsuit with Merck & Co. regarding Keytruda
January 22, 2017Bristol-Myers Squibb and Ono Pharmaceutical on Friday announced that they have reached an agreement with Merck & Co. to settle patent-infringement litigation regarding the latter's PD-1 antibody Keytruda (pembrolizumab). -
Investigators line up Keytruda, cancer vax combo trial in glioblastoma
January 19, 2017In what could see another use added to Merck & Co.’s immuno-oncology star Keytruda, the checkpoint inhibitor is set for testing in glioblastoma as part of a combo with Agenus’ cancer vaccine Prophage.
Pharma Sources Insight January 2025
